GoodRx Holdings (GDRX) Financial Statements & Analysis

GoodRx Holdings (GDRX) Income Statement

GoodRx Holdings reported revenue of $796.85M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 0.6% from $792.32M a year earlier. Net income was $30.44M, up 85.7% year over year, a net margin of 3.8%. Gross margin was 92.8% and operating margin 11.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $200.41M, down 1.3% from the same quarter a year earlier.

GoodRx Holdings Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

GoodRx Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	796.85	792.32	750.27	766.55	745.42	550.70	388.22	249.52
Cost of Revenue	57.60	48.22	62.43	65.08	46.72	29.59	14.02	6.04
Gross Profit	739.26	744.11	683.34	701.48	698.71	521.11	374.21	243.49
Operating Expenses
Research & Development	121.03	123.75	126.44	143.14	125.86	61.82	29.30	43.89
Selling, General & Administrative	445.52	484.98	450.94	502.42	524.90	714.52	191.66	112.54
Operating Expenses	651.76	678.26	710.35	699.74	685.30	794.76	234.53	166.24
Operating Income	87.49	65.85	-27.01	1.74	13.41	-273.65	139.68	77.25
Other Income/Expense
Interest Income	10.93	23.27	32.17	9.27	0.06	0.16	0.72	0.15
Interest Expense	42.61	52.92	-56.73	34.24	-23.64	-27.91	49.57	22.19
Other Income/Expense	-30.95	-4.74	28.57	-24.97	23.58	0.02	-56.70	-24.90
Income
Income Before Tax	56.54	31.46	-55.57	-23.23	-10.18	-303.45	82.98	52.35
Income Tax Expense	26.10	15.07	-46.70	9.60	15.08	-9.83	16.93	8.56
Net Income	30.44	16.39	-8.87	-32.83	-25.25	-293.62	66.05	43.79
Net Income - Continuous Operations	30.44	16.39	-8.87	-32.83	-25.25	-293.62	66.05	43.79
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	184.36	153.92	66.57	65.19	35.75	-259.62	146.12	84.35
EBIT	99.14	84.38	49.50	19.80	13.41	-273.65	-	-
Depreciation & Amortization	85.22	69.54	17.07	54.18	22.34	14.03	13.57	9.81
Earnings Per Share
Basic EPS	-	-	-	-	-	-1.00	-	-
Diluted EPS	-	-	-	-	-	-1.00	-	-
Basic Shares Outstanding	356.33	385.74	410.32	412.86	409.98	274.70	356.07	356.07
Diluted Shares Outstanding	356.97	392.17	410.32	412.86	409.98	274.70	362.60	362.60

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About GoodRx Holdings Financial Statements

What was GoodRx Holdings's revenue in fiscal 2025?

GoodRx Holdings reported revenue of $796.85M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 0.6% from $792.32M a year earlier.

Is GoodRx Holdings profitable?

Yes. GoodRx Holdings earned net income of $30.44M in fiscal 2025, a net margin of 3.8%. In fiscal 2024 it earned $16.39M.

What is GoodRx Holdings's operating margin?

GoodRx Holdings's operating income was $87.49M on revenue of $796.85M in fiscal 2025, an operating margin of 11.0%, compared with 8.3% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition